scholarly journals Mandibular resection in patients with head and neck cancer: acute and long-term complications after reconstruction

2022 ◽  
pp. 1-6
Author(s):  
Mats Sjöström ◽  
Daniel Danielsson ◽  
Eva Munck-Wikland ◽  
Jan Nyberg ◽  
Karl Sandström ◽  
...  
2021 ◽  
Vol 11 (5) ◽  
pp. 393
Author(s):  
Francesca De Felice ◽  
Daniela Musio ◽  
Vincenzo Tombolini

In head and neck cancer management, there is a need for tailored approaches to optimally implement clinical outcomes. Based on the assumption that efficacy and long-term toxicity are not satisfactory for standard concurrent platinum-based chemoradiotherapy, several trials have been designed to test whether induction immunotherapy and/or concomitant immunotherapy and radiotherapy result in improved survival and toxicity outcomes. Here, we present an overview of the most recent concomitant therapeutic strategies for head and neck cancer, focusing on the knowledge available regarding check-point inhibitors. The aim is to present the characteristics of the main check-point inhibitors and to summarize the clinical trials on the combination of immune check-point inhibitors and (chemo)radiotherapy in the definitive HNC setting, in order to provide a useful clinical tool for further research.


2017 ◽  
Vol 66 (4) ◽  
pp. e91-e92
Author(s):  
Roy W. Jones ◽  
Adam Tanious ◽  
Paul Armstrong ◽  
Neil Moudgill ◽  
Karl A. Illig ◽  
...  

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Chen-Shuan Chung ◽  
Wu-Chia Lo ◽  
Ming-Hsun Wen ◽  
Chen-Hsi Hsieh ◽  
Yu-Chin Lin ◽  
...  

2018 ◽  
Vol 47 (6) ◽  
pp. 783-788 ◽  
Author(s):  
M.M. Curi ◽  
A.F.B. Condezo ◽  
K.d.C.B. Ribeiro ◽  
C.L. Cardoso

2020 ◽  
Vol 9 (5) ◽  
pp. 1712-1720
Author(s):  
Shengjin Dou ◽  
Rongrong Li ◽  
Lin Zhang ◽  
Zhuoying Wang ◽  
Li Xie ◽  
...  

Author(s):  
A. Lee ◽  
S. Kitpanit ◽  
P.B. Romesser ◽  
K. Sine ◽  
J.J. Kang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document